Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Lisinopril in Hypertensive Nephropathy
NCT00171600Phase 4Terminated
- Sponsor
- Novartis
- Start
- Jul 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of valsartan in hypertension (HTN), diabetic nephropathy (DN) and chronic kidney disease (CKD) (3 arms), sponsored by Novartis. Primary endpoint: Change from baseline in urine albumin excretion rate at 20 weeks. Started Jul 2005; status: terminated.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)diabetic nephropathy (DN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00171600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171600.